ACM
Aquilo Capital Management Portfolio holdings
AUM
$37.1M
1-Year Est. Return
36.49%
1 Year Est. Return
-36.49%
AUM
$58.4M
AUM Growth
-$30.5M
(-34%)
Holding
16
Top Buys
| 1 | +$2.96M | |
| 2 | +$589K | |
| 3 | +$560K | |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$436K |
| 5 |
Repare Therapeutics
RPTX
|
+$399K |
Top Sells
| 1 | +$5.89M | |
| 2 | +$4.52M | |
| 3 | +$1.66M | |
| 4 |
Sutro Biopharma
STRO
|
+$1.4M |
| 5 |
Arvinas
ARVN
|
+$1.15M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arrowhead Research
ARWR
$5.48B
| $13.3M | 20.06% |
707,589
-88,224
|
|
||
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $11.3M | 17.04% |
129,600
+5,000
|
|
||
3
Kymera Therapeutics
KYMR
$4.27B
| $7.38M | 11.13% |
183,521
-25,222
|
|
||
|
4
Arvinas
ARVN
$714M
| $6.3M | 9.5% |
328,766
-60,000
|
|
||
|
BCYC
5
Bicycle Therapeutics
BCYC
$503M
| $3.11M | 4.68% |
221,911
+40,000
|
|
||
6
Protagonist Therapeutics
PTGX
$4.72B
| $2.96M | 4.46% |
+76,592
|
|
||
7
Regenxbio
RGNX
$606M
| $2.68M | 4.04% |
346,302
-584,406
|
|
||
8
Immatics
IMTX
$1.18B
| $2.66M | 4.01% |
373,902
+40,400
|
|
||
|
SLN
9
Silence Therapeutics
SLN
$312M
| $2.53M | 3.81% |
367,214
+50,000
|
|
||
10
Adicet Bio
ACET
$112M
| $2.44M | 3.67% |
2,531,194
|
|
||
11
Precision BioSciences
DTIL
$86.8M
| $2.04M | 3.08% |
536,376
+154,573
|
|
||
|
12
Repare Therapeutics
RPTX
$79M
| $1.69M | 2.56% |
1,293,715
+304,351
|
|
||
|
13
Sutro Biopharma
STRO
$93.3M
| $916 | ﹤0.01% |
498
-762,000
|
|
||
14
Amgen
AMGN
$160B
| – | – |
0
|
|
||
15
Merus
MRUS
$7.18B
| – | – |
-117,855
|
|
||
16
SPDR S&P 500 ETF Trust
SPY
$679B
| – | – |
0
|
|